elacestrant
Stemline Therap
To treat estrogen receptor-positive, human epidermal growth factor receptor 2-negative, ESR1-mutated, advanced or metastatic breast cancer with disease progression following at least one line of endocrine therapy
The fda-analyst skill answers natural-language questions about this approval by fetching the relevant FDA review PDFs at query time.
git clone https://github.com/cbetz/trove
cp -r trove/skills/fda-analyst ~/.claude/skills/
Example prompts for Orserdu: